Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-08
DOI
10.3389/fphar.2019.01315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased miR-29b expression is associated with airway inflammation in chronic obstructive pulmonary disease
- (2019) Kun Tang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway
- (2019) Han Guan et al. Cancer Medicine
- Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy
- (2019) Carolina Lavoz et al. KIDNEY INTERNATIONAL
- Preclinical Targeting of MicroRNA-214 in Cutaneous T-cell Lymphoma (CTCL)
- (2019) Rebecca Kohnken et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
- (2019) Jérôme Piquereau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emerging roles of and therapeutic strategies targeting BRD4 in cancer
- (2019) Mary E. White et al. CELLULAR IMMUNOLOGY
- Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis
- (2019) Carrie B. Wiese et al. ATHEROSCLEROSIS
- Heterogeneity and emergent behaviour in the vascular endothelium
- (2019) John G McCarron et al. CURRENT OPINION IN PHARMACOLOGY
- MicroRNA-146b-5p protects oligodendrocyte precursor cells from oxygen/glucose deprivation-induced injury through regulating Keap1/Nrf2 signaling via targeting bromodomain-containing protein 4
- (2019) Xiaoquan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling
- (2019) Hu Song et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bromodomain-containing protein 4 contributes to renal fibrosis through the induction of epithelial-mesenchymal transition
- (2019) Xuan Wang et al. EXPERIMENTAL CELL RESEARCH
- 41OA phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma
- (2018) K A Blum et al. ANNALS OF ONCOLOGY
- microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4
- (2018) Ling He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of BET bromodomains restores corticosteroid responsiveness in a mixed granulocytic mouse model of asthma
- (2018) Ahmed Nadeem et al. BIOCHEMICAL PHARMACOLOGY
- JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21
- (2018) Yan Zhang et al. CHEMICAL RESEARCH IN TOXICOLOGY
- New insights into TGF-β/Smad signaling in tissue fibrosis
- (2018) He-He Hu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease
- (2018) Yue Wang et al. Journal of Translational Medicine
- Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease
- (2018) Ewelina Kulikowski et al. KIDNEY & BLOOD PRESSURE RESEARCH
- BRD4 regulates cellular senescence in gastric cancer cells via E2F/miR-106b/p21 axis
- (2018) Xingchen Dong et al. Cell Death & Disease
- Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis
- (2018) Jian Wang et al. Scientific Reports
- miR-21 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Preventing Epithelial Cell Apoptosis and Inhibiting Dendritic Cell Maturation
- (2018) Nana Song et al. Frontiers in Physiology
- Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
- (2018) Afua A. Mensah et al. HAEMATOLOGICA
- The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells
- (2018) Bing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase ib/2a study of PLX51107, a small molecule BET inhibitor, in subjects with advanced hematological malignancies and solid tumors.
- (2018) Amita Patnaik et al. JOURNAL OF CLINICAL ONCOLOGY
- Apabetalone downregulates factors and pathways associated with vascular calcification
- (2018) Dean Gilham et al. ATHEROSCLEROSIS
- Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
- (2018) Jose Luis Morgado-Pascual et al. MEDIATORS OF INFLAMMATION
- Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis
- (2018) Shuai Song et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations
- (2017) Mark C. Markowski et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MicroRNA-92a Mediates Endothelial Dysfunction in CKD
- (2017) Fenqing Shang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
- (2017) B Sun et al. LEUKEMIA
- RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease
- (2017) Ravi Jahagirdar et al. MOLECULAR PHARMACOLOGY
- Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
- (2017) Malte Kölling et al. MOLECULAR THERAPY
- Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
- (2017) Mathias Haarhaus et al. Nature Reviews Nephrology
- BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice
- (2017) Kalung Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
- (2017) Qiming Duan et al. Science Translational Medicine
- Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis
- (2017) Carole Henique et al. Nature Communications
- Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis
- (2017) Congcong Chen et al. Scientific Reports
- Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression
- (2017) Baoshang Zhou et al. Redox Biology
- Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation
- (2016) Qiong Duan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation
- (2016) Mingcheng Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
- (2016) Yasushi Taniguchi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells
- (2016) Malihe Eskandarpour et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage
- (2016) Beatriz Suarez-Alvarez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension
- (2016) Sharon Mumby et al. RESPIROLOGY
- Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis
- (2016) Sara Lovisa et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
- (2016) Chongxiang Xiong et al. Oncotarget
- Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling
- (2016) Yung-Chien Hsu et al. Scientific Reports
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
- (2016) Sandy Amorim et al. Lancet Haematology
- Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD
- (2015) Xia Zhou et al. HUMAN MOLECULAR GENETICS
- Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis
- (2015) Qing-gang Zhang et al. IMMUNOLOGY LETTERS
- Interleukin-17 and innate immunity in infections and chronic inflammation
- (2015) Natasa Isailovic et al. JOURNAL OF AUTOIMMUNITY
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRD4 is a novel therapeutic target for liver fibrosis
- (2015) Ning Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- MicroRNA-21 Attenuates Renal Ischemia Reperfusion Injury via Targeting Caspase Signaling in Mice
- (2014) Honglin Hu et al. AMERICAN JOURNAL OF NEPHROLOGY
- The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts
- (2014) Kerstin Klein et al. ANNALS OF THE RHEUMATIC DISEASES
- A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
- (2014) Ravi Jahagirdar et al. ATHEROSCLEROSIS
- The bromodomain: From epigenome reader to druggable target
- (2014) Roberto Sanchez et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Calcifying vascular smooth muscle cells and osteoblasts: independent cell types exhibiting extracellular matrix and biomineralization-related mimicries
- (2014) Rodrigo DAM Alves et al. BMC GENOMICS
- A Chromatin-Dependent Role of the Fragile X Mental Retardation Protein FMRP in the DNA Damage Response
- (2014) Roman Alpatov et al. CELL
- Role of Transcription Factor Acetylation in Diabetic Kidney Disease
- (2014) R. Liu et al. DIABETES
- Mechanistic Analysis of the Role of Bromodomain-containing Protein 4 (BRD4) in BRD4-NUT Oncoprotein-induced Transcriptional Activation
- (2014) Ranran Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction
- (2014) S. Meng et al. JOURNAL OF DENTAL RESEARCH
- miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy
- (2014) Jin-Yang Wang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells
- (2014) Tae-Yoon Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brd4 is on the move during inflammation
- (2014) Yali Xu et al. TRENDS IN CELL BIOLOGY
- Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
- (2014) Kyung-Hyun Park-Min et al. Nature Communications
- Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
- (2014) Jessica E. Bolden et al. Cell Reports
- Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population
- (2013) Jonathan J. Taliercio et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis
- (2013) Xiaoyan Tang et al. AMERICAN JOURNAL OF PATHOLOGY
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
- (2013) Priti Anand et al. CELL
- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- Glycemic Memories and the Epigenetic Component of Diabetic Nephropathy
- (2013) Samuel T. Keating et al. Current Diabetes Reports
- Bromodomain and Extraterminal (BET) Protein Inhibition Suppresses Human T Cell Leukemia Virus 1 (HTLV-1) Tax Protein-mediated Tumorigenesis by Inhibiting Nuclear Factor κB (NF-κB) Signaling
- (2013) Xuewei Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BET bromodomain inhibition suppresses TH17-mediated pathology
- (2013) Deanna A. Mele et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
- BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
- (2013) Jessica I. Spiltoir et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response
- (2013) Raquel Rodrigues-Díez et al. LABORATORY INVESTIGATION
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1
- (2013) Christoph A Gebeshuber et al. NATURE MEDICINE
- Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
- (2013) Z Zou et al. ONCOGENE
- Transcription of Il17 and Il17f Is Controlled by Conserved Noncoding Sequence 2
- (2012) Xiaohu Wang et al. IMMUNITY
- Cancer research: Open ambition
- (2012) Amy Maxmen NATURE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors
- (2012) H. S. Bandukwala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
- (2012) B. N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Chemokines in Renal Injury
- (2011) A. C. K. Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction
- (2011) Jana Pindjakova et al. KIDNEY INTERNATIONAL
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- MicroRNAs in development and disease
- (2009) AE Erson et al. CLINICAL GENETICS
- IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
- (2008) Colin Edgerton et al. CLINICAL IMMUNOLOGY
- Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation
- (2008) Liselotte Bäckdahl et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Brd4 Coactivates Transcriptional Activation of NF- B via Specific Binding to Acetylated RelA
- (2008) B. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- Small non-coding RNAs in animal development
- (2008) Giovanni Stefani et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search